364 related articles for article (PubMed ID: 24032459)
1. Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure.
Gong W; Duan Q; Cai Z; Chen C; Ni L; Yan M; Wang X; Cianflone K; Wang DW
Br J Pharmacol; 2013 Dec; 170(7):1396-409. PubMed ID: 24032459
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress regulates left ventricular PDE5 expression in the failing heart.
Lu Z; Xu X; Hu X; Lee S; Traverse JH; Zhu G; Fassett J; Tao Y; Zhang P; dos Remedios C; Pritzker M; Hall JL; Garry DJ; Chen Y
Circulation; 2010 Apr; 121(13):1474-83. PubMed ID: 20308615
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.
Nishida M; Watanabe K; Sato Y; Nakaya M; Kitajima N; Ide T; Inoue R; Kurose H
J Biol Chem; 2010 Apr; 285(17):13244-53. PubMed ID: 20177073
[TBL] [Abstract][Full Text] [Related]
4. Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis.
Patrucco E; Domes K; Sbroggió M; Blaich A; Schlossmann J; Desch M; Rybalkin SD; Beavo JA; Lukowski R; Hofmann F
Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12925-9. PubMed ID: 25139994
[TBL] [Abstract][Full Text] [Related]
5. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
Okada K; Minamino T; Tsukamoto Y; Liao Y; Tsukamoto O; Takashima S; Hirata A; Fujita M; Nagamachi Y; Nakatani T; Yutani C; Ozawa K; Ogawa S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):705-12. PubMed ID: 15289376
[TBL] [Abstract][Full Text] [Related]
6. Chronic inhibition of cyclic guanosine monophosphate-specific phosphodiesterase 5 prevented cardiac fibrosis through inhibition of transforming growth factor β-induced Smad signaling.
Gong W; Yan M; Chen J; Chaugai S; Chen C; Wang D
Front Med; 2014 Dec; 8(4):445-55. PubMed ID: 25416030
[TBL] [Abstract][Full Text] [Related]
7. Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation.
Nakamura T; Zhu G; Ranek MJ; Kokkonen-Simon K; Zhang M; Kim GE; Tsujita K; Kass DA
Circ Heart Fail; 2018 Mar; 11(3):e004740. PubMed ID: 29545395
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
Xie YP; Chen B; Sanders P; Guo A; Li Y; Zimmerman K; Wang LC; Weiss RM; Grumbach IM; Anderson ME; Song LS
Hypertension; 2012 Feb; 59(2):355-62. PubMed ID: 22203744
[TBL] [Abstract][Full Text] [Related]
9. Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions.
Wilson LS; Elbatarny HS; Crawley SW; Bennett BM; Maurice DH
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13650-5. PubMed ID: 18757735
[TBL] [Abstract][Full Text] [Related]
10. PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation.
Lee DI; Vahebi S; Tocchetti CG; Barouch LA; Solaro RJ; Takimoto E; Kass DA
Basic Res Cardiol; 2010 May; 105(3):337-47. PubMed ID: 20107996
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway.
Hsu S; Nagayama T; Koitabashi N; Zhang M; Zhou L; Bedja D; Gabrielson KL; Molkentin JD; Kass DA; Takimoto E
Cardiovasc Res; 2009 Feb; 81(2):301-9. PubMed ID: 19029137
[TBL] [Abstract][Full Text] [Related]
12. Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice.
Takimoto E; Koitabashi N; Hsu S; Ketner EA; Zhang M; Nagayama T; Bedja D; Gabrielson KL; Blanton R; Siderovski DP; Mendelsohn ME; Kass DA
J Clin Invest; 2009 Feb; 119(2):408-20. PubMed ID: 19127022
[TBL] [Abstract][Full Text] [Related]
13. cGMP-hydrolytic activity and its inhibition by sildenafil in normal and failing human and mouse myocardium.
Vandeput F; Krall J; Ockaili R; Salloum FN; Florio V; Corbin JD; Francis SH; Kukreja RC; Movsesian MA
J Pharmacol Exp Ther; 2009 Sep; 330(3):884-91. PubMed ID: 19546307
[TBL] [Abstract][Full Text] [Related]
14. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.
Westermann D; Becher PM; Lindner D; Savvatis K; Xia Y; Fröhlich M; Hoffmann S; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2012 Nov; 107(6):308. PubMed ID: 23117837
[TBL] [Abstract][Full Text] [Related]
15. Increased cardiac myocyte PDE5 levels in human and murine pressure overload hypertrophy contribute to adverse LV remodeling.
Vandenwijngaert S; Pokreisz P; Hermans H; Gillijns H; Pellens M; Bax NA; Coppiello G; Oosterlinck W; Balogh A; Papp Z; Bouten CV; Bartunek J; D'hooge J; Luttun A; Verbeken E; Herregods MC; Herijgers P; Bloch KD; Janssens S
PLoS One; 2013; 8(3):e58841. PubMed ID: 23527037
[TBL] [Abstract][Full Text] [Related]
16. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
[TBL] [Abstract][Full Text] [Related]
17. Expression, activity, and pro-hypertrophic effects of PDE5A in cardiac myocytes.
Zhang M; Koitabashi N; Nagayama T; Rambaran R; Feng N; Takimoto E; Koenke T; O'Rourke B; Champion HC; Crow MT; Kass DA
Cell Signal; 2008 Dec; 20(12):2231-6. PubMed ID: 18790048
[TBL] [Abstract][Full Text] [Related]
18. Distinct allostery induced in the cyclic GMP-binding, cyclic GMP-specific phosphodiesterase (PDE5) by cyclic GMP, sildenafil, and metal ions.
Biswas KH; Visweswariah SS
J Biol Chem; 2011 Mar; 286(10):8545-8554. PubMed ID: 21193396
[TBL] [Abstract][Full Text] [Related]
19. Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.
Koitabashi N; Aiba T; Hesketh GG; Rowell J; Zhang M; Takimoto E; Tomaselli GF; Kass DA
J Mol Cell Cardiol; 2010 Apr; 48(4):713-24. PubMed ID: 19961855
[TBL] [Abstract][Full Text] [Related]
20. PDE5 inhibitor efficacy is estrogen dependent in female heart disease.
Sasaki H; Nagayama T; Blanton RM; Seo K; Zhang M; Zhu G; Lee DI; Bedja D; Hsu S; Tsukamoto O; Takashima S; Kitakaze M; Mendelsohn ME; Karas RH; Kass DA; Takimoto E
J Clin Invest; 2014 Jun; 124(6):2464-71. PubMed ID: 24837433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
